Fluvastatin enhances sorafenib cytotoxicity in melanoma cells via modulation of AKT and JNK signaling pathways. [electronic resource]
Producer: 20111122Description: 3259-65 p. digitalISSN:- 1791-7530
- Anthracenes -- pharmacology
- Benzenesulfonates -- pharmacology
- Cell Death -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Chromones -- pharmacology
- Drug Screening Assays, Antitumor
- Drug Synergism
- Enzyme Activation -- drug effects
- Fatty Acids, Monounsaturated -- pharmacology
- Fluvastatin
- Humans
- Indoles -- pharmacology
- JNK Mitogen-Activated Protein Kinases -- metabolism
- Melanoma -- enzymology
- Morpholines -- pharmacology
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Poly(ADP-ribose) Polymerases -- metabolism
- Proto-Oncogene Proteins c-akt -- metabolism
- Pyridines -- pharmacology
- Signal Transduction -- drug effects
- Sorafenib
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.